85 related articles for article (PubMed ID: 1380769)
1. Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases.
Loy TS; Quesenberry JT; Sharp SC
Am J Clin Pathol; 1992 Aug; 98(2):175-9. PubMed ID: 1380769
[TBL] [Abstract][Full Text] [Related]
2. Distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas. An immunohistochemical study of 527 cases.
Loy TS; Sharp SC; Andershock CJ; Craig SB
Am J Clin Pathol; 1993 Jun; 99(6):726-8. PubMed ID: 8322708
[TBL] [Abstract][Full Text] [Related]
3. Distribution of colon-ovarian tumor antigen in adenocarcinomas. An immunohistochemical study of 501 cases.
Loy TS; Darkow GV
Am J Clin Pathol; 1993 Feb; 99(2):207-10. PubMed ID: 7679875
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of B72.3 with adenocarcinomas. An immunohistochemical study of 476 cases.
Loy TS; Nashelsky MB
Cancer; 1993 Oct; 72(8):2495-8. PubMed ID: 8402466
[TBL] [Abstract][Full Text] [Related]
5. Nonspecificity of colon-specific antigen in adenocarcinomas. An immunohistochemical study of 422 cases.
Loy TS; Chapman RK; White L; Diaz-Arias AA; Bickel JT
Am J Clin Pathol; 1992 Apr; 97(4):490-2. PubMed ID: 1553913
[TBL] [Abstract][Full Text] [Related]
6. Distribution of BCA-225 in adenocarcinomas. An immunohistochemical study of 446 cases.
Loy TS; Chapman RK; Diaz-Arias AA; Bulatao IS; Bickel JT
Am J Clin Pathol; 1991 Sep; 96(3):326-9. PubMed ID: 1877528
[TBL] [Abstract][Full Text] [Related]
7. CA-549 is not diagnostically useful as an immunohistochemical marker for breast carcinoma.
Hoagland MH; Hafer LJ; Demers LM
Arch Pathol Lab Med; 1992 Sep; 116(9):938-42. PubMed ID: 1524458
[TBL] [Abstract][Full Text] [Related]
8. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
9. Immunostaining with HAM56 in the diagnosis of adenocarcinomas.
Loy TS; Abshier J
Mod Pathol; 1993 Jul; 6(4):473-5. PubMed ID: 8415595
[TBL] [Abstract][Full Text] [Related]
10. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
11. Expression of carbohydrate antigens in human pulmonary adenocarcinoma.
Kawai T; Suzuki M; Kase K; Ozeki Y
Cancer; 1993 Sep; 72(5):1581-7. PubMed ID: 8394200
[TBL] [Abstract][Full Text] [Related]
12. Expression of the antigenic determinant recognized by the monoclonal antibody 44-3A6 on select human adenocarcinomas and normal human tissues.
Combs SG; Radosevich JA; Ma Y; Lee I; Gould VE; Battifora H; Rosen ST
Tumour Biol; 1988; 9(2-3):116-22. PubMed ID: 2456598
[TBL] [Abstract][Full Text] [Related]
13. Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1991 Mar; 63(3):386-9. PubMed ID: 1848439
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
Gomez-Fernandez C; Mejias A; Walker G; Nadji M
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):137-41. PubMed ID: 19875957
[TBL] [Abstract][Full Text] [Related]
15. Sialosyl-Tn antigen. Its distribution in normal human tissues and expression in adenocarcinomas.
Yonezawa S; Tachikawa T; Shin S; Sato E
Am J Clin Pathol; 1992 Aug; 98(2):167-74. PubMed ID: 1510031
[TBL] [Abstract][Full Text] [Related]
16. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
18. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.
Scharl A; Crombach G; Vierbuchen M; Müsch H; Bolte A
Arch Gynecol Obstet; 1989; 244(2):103-12. PubMed ID: 2712596
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
Berchuck A; Soisson AP; Clarke-Pearson DL; Soper JT; Boyer CM; Kinney RB; McCarty KS; Bast RC
Cancer Res; 1989 Apr; 49(8):2091-5. PubMed ID: 2702650
[TBL] [Abstract][Full Text] [Related]
20. Lack of specificity of monoclonal antibody B72.3 in distinguishing chronic pancreatitis from pancreatic adenocarcinoma.
Loy TS; Springer D; Chapman RK; Diaz-Arias AA; Bulatao IS; Bickel JT
Am J Clin Pathol; 1991 Dec; 96(6):684-8. PubMed ID: 1720919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
